Graham Capital Management’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,243
Closed -$204K 1429
2024
Q1
$204K Buy
+14,243
New +$202K ﹤0.01% 895
2023
Q3
Sell
-20,996
Closed -$159K 1335
2023
Q2
$159K Sell
20,996
-55,503
-73% -$424K ﹤0.01% 851
2023
Q1
$612K Buy
76,499
+48,229
+171% +$496K 0.02% 680
2022
Q4
$321K Sell
28,270
-42,501
-60% -$464K 0.01% 869
2022
Q3
$617K Sell
70,771
-9,891
-12% -$103K 0.02% 677
2022
Q2
$803K Buy
+80,662
New +$812K 0.03% 509

Other funds holding PTVE

Graham Capital Management's PTVE Position: Q2 2024 in Review

Graham Capital Management sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2024, closing a stake of 14,243 shares — an estimated $204K sold.

Graham Capital Management first reported a position in PTVE in Q2 2022 and held it in 6 quarters. The position peaked at $803K in Q2 2022. 142 funds tracked by Wall St. Rank hold PTVE as of Q2 2024.

  • Graham Capital Management reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2024 after selling out during the quarter.
  • Graham Capital Management sold 14,243 Pactiv Evergreen Inc. Common stock shares in Q2 2024, an estimated $204K.
  • Graham Capital Management first reported a position in Pactiv Evergreen Inc. Common stock in Q2 2022 and held it in 6 quarters.
  • Graham Capital Management's Pactiv Evergreen Inc. Common stock position peaked at $803K in Q2 2022.
  • 142 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2024.

Based on Graham Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.